FORMATION OF A QUATERNARY N-GLUCURONIDE OF AMITRIPTYLINE IN HUMAN-LIVER MICROSOMES

被引：23

作者：

DAHLPUUSTINEN, ML

BERTILSSON, L

机构：

来源：

PHARMACOLOGY & TOXICOLOGY | 1987年 / 61卷 / 05期

关键词：

D O I：

10.1111/j.1600-0773.1987.tb01832.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：342 / 346

页数：5

共 20 条

[1] URINARY-EXCRETION OF NORTRIPTYLINE AND 5 OF ITS METABOLITES IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES [J].

ALEXANDERSON, B ;

BORGA, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) :174-180

[2] ROLE OF OXIDATION POLYMORPHISM ON BLOOD AND URINE CONCENTRATIONS OF AMITRIPTYLINE AND ITS METABOLITES IN MAN [J].

BALANTGORGIA, AE ;

SCHULZ, P ;

DAYER, P ;

BALANT, L ;

KUBLI, A ;

GERTSCH, C ;

GARRONE, G .

ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 232 (03) :215-222

[3] STEREOSPECIFIC HYDROXYLATION OF NORTRIPTYLINE IN MAN IN RELATION TO INTERINDIVIDUAL DIFFERENCES IN ITS STEADY-STATE PLASMA LEVEL [J].

BERTILSSON, L ;

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (04) :201-+

[4] DISPOSITION OF SINGLE ORAL DOSES OF E-10-HYDROXYNORTRIPTYLINE IN HEALTHY-SUBJECTS, WITH SOME OBSERVATIONS ON PHARMACODYNAMIC EFFECTS [J].

BERTILSSON, L ;

NORDIN, C ;

OTANI, K ;

RESUL, B ;

SCHEININ, M ;

SIWERS, B ;

SJOQVIST, F .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :261-267

[5]

BIGGS SR, 1979, DRUG METAB DISPOS, V7, P233

[6] DETERMINATION OF MICROSOMAL UDP-GLUCURONYLTRANSFERASE IN NEEDLE-BIOPSY SPECIMENS OF HUMAN LIVER [J].

BOCK, KW ;

BRUNNER, G ;

HOENSCH, H ;

HUBER, E ;

JOSTING, D .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (05) :367-373

[7]

BOCK KW, 1984, DRUG METAB DISPOS, V12, P93

[8] UDP-GLUCURONOSYLTRANSFERASE ACTIVITIES - GUIDELINES FOR CONSISTENT INTERIM TERMINOLOGY AND ASSAY CONDITIONS [J].

BOCK, KW ;

BURCHELL, B ;

DUTTON, GJ ;

HANNINEN, O ;

MULDER, GJ ;

OWENS, IS ;

SIEST, G ;

TEPHLY, TR .

BIOCHEMICAL PHARMACOLOGY, 1983, 32 (06) :953-955

[9]

BREYERPFAFF U, 1978, ARZNEIMITTEL-FORSCH, V28, P1916

[10]

CHAUDHURI NK, 1976, DRUG METAB DISPOS, V4, P372

← 1 2 →